Drawing lessons from the clinical development of antibody-drug conjugates

Volume: 30, Pages: 105 - 109
Published: Dec 1, 2018
Abstract
The antibody-drug conjugate (ADC) field has seen a remarkable expansion in the number of entrants in clinical studies. Many of these agents employ newer conjugation technologies that have been developed over the last decade that confer various attributes to the ADCs prepared with them, including stability, potency, and homogeneity. In many cases, these new ADCs appear demonstrably superior to earlier technologies in preclinical models of...
Paper Details
Title
Drawing lessons from the clinical development of antibody-drug conjugates
Published Date
Dec 1, 2018
Volume
30
Pages
105 - 109
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.